Schedule II Condensed Financial Information of Registrant Statements of Cash Flows (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flows from Operating Activities:
Net loss	$ (5,733,658)	$ (5,065,534)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation	58,761	147,761
Stock options	21,745
Other assets and liabilities	4,745,274	175,344
Net cash provided (used) by operating activities	(2,457,176)	(20,369,748)
Cash Flows from Investing Activities:
Net (purchases) disposals of property and equipment	(45,634)	(12,747)
Net cash (used) provided by investing activities	(117,890,852)	1,862,609
Cash Flows from Financing Activities:
Proceeds from issuance of preferred stock		1,500,000
Proceeds for issuance of notes		18,938,705
Net cash provided by financing activities	161,231,666	20,388,179
Net increase (decrease) in cash and cash equivalents	40,883,638	1,881,040
Cash and cash equivalents:
Beginning	2,832,567
Ending	43,716,205	2,832,567
Conversion of notes payable
Book value of note payable	(19,100,000)
Common stock	927,680
Additional paid in capital	18,172,320
Conversion of preferred stock
Book value of preferred stock	(1,500,000)
Common stock	72,855
Additional paid in capital	1,427,145
Total
Parent Company [Member]
Cash Flows from Operating Activities:
Net loss	(5,733,658)	(5,065,534)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Equity in net loss of consolidated subsidiaries	4,396,148	5,199,248
Depreciation	(3,500)	22,245
Preferred stock dividend	845,536
Stock options	21,745
Net transfers to noncontrolling interest	124,477
Other assets and liabilities	274,451	(17,604)
Net cash provided (used) by operating activities	(74,801)	138,355
Cash Flows from Investing Activities:
Purchase of preferred stock	(500,000)
Net (purchases) disposals of property and equipment		(2,569)
Net cash (used) provided by investing activities	(500,000)	(2,569)
Cash Flows from Financing Activities:
Proceeds from issuance of preferred stock		1,500,000
Note payable to American Life	500,000
Proceeds for issuance of notes		18,938,705
Capital contribution to American Life		(20,500,000)
Net cash provided by financing activities	500,000	(61,295)
Net increase (decrease) in cash and cash equivalents	(74,801)	74,491
Cash and cash equivalents:
Beginning	79,247	4,756
Ending	4,446	$ 79,247
Conversion of notes payable
Book value of note payable	(19,100,000)
Common stock	927,680
Additional paid in capital	18,172,320
Conversion of preferred stock
Book value of preferred stock	(1,500,000)
Common stock	72,855
Additional paid in capital	$ 1,427,145